Fasciola hepaticasurface tegument: glycoproteins at the interface of parasite and host
Ravidà, Alessandra Cwiklinski, Krystyna Aldridge, Allison M. Clarke, Paul Thompson, Roisin Gerlach, Jared Q. Kilcoyne, Michelle Hokke, Cornelis H. Dalton, John P. O'Neill, Sandra M.
Ravidà, Alessandra
Cwiklinski, Krystyna
Aldridge, Allison M.
Clarke, Paul
Thompson, Roisin
Gerlach, Jared Q.
Kilcoyne, Michelle
Hokke, Cornelis H.
Dalton, John P.
O'Neill, Sandra M.
Publication Date
2016-07-27
Type
Article
Downloads
Citation
Ravidà, Alessandra; Cwiklinski, Krystyna; Aldridge, Allison M. Clarke, Paul; Thompson, Roisin; Gerlach, Jared Q.; Kilcoyne, Michelle; Hokke, Cornelis H.; Dalton, John P.; O'Neill, Sandra M. (2016). Fasciola hepaticasurface tegument: glycoproteins at the interface of parasite and host. Molecular & Cellular Proteomics 15 (10), 3139-3153
Abstract
Fasciola hepatica, commonly known as liver fluke, is a trematode that causes Fasciolosis in ruminants and humans. The outer tegumental coat of F. hepatica (FhTeg) is a complex metabolically active biological matrix that is continually exposed to the host immune system and therefore makes a good vaccine target. F. hepatica tegumental coat is highly glycosylated and helminth-derived immunogenic oligosaccharide motifs and glycoproteins are currently being investigated as novel vaccine candidates. This report presents the first systematic characterization of FhTeg glycosylation using lectin microarrays to characterize carbohydrates motifs present, and lectin histochemistry to localize these on the F. hepatica tegument. We discovered that FhTeg glycoproteins are predominantly oligomannose oligosaccharides that are expressed on the spines, suckers and tegumental coat of F. hepatica and lectin blot analysis confirmed the abundance of N-glycosylated proteins. Although some oligosaccharides are widely distributed on the fluke surface other subsets are restricted to distinct anatomical regions. We selectively enriched for FhTeg mannosylated glycoprotein subsets using lectin affinity chromatography and identified 369 proteins by mass spectrometric analysis. Among these proteins are a number of potential vaccine candidates with known immune modulatory properties including proteases, protease inhibitors, paramyosin, Venom Allergen-like II, Enolase and two proteins, nardilysin and TRIL, that have not been previously associated with F. hepatica. Furthermore, we provide a comprehensive insight regarding the putative glycosylation of FhTeg components that could highlight the importance of further studies examining glycoconjugates in host-parasite interactions in the context of F. hepatica infection and the development of an effective vaccine.
Funder
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland